125 related articles for article (PubMed ID: 15928252)
21. Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy.
De Bellis A; Sansone D; Coronella C; Conte M; Iorio S; Perrino S; Battaglia M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
Clin Endocrinol (Oxf); 2005 Jan; 62(1):24-9. PubMed ID: 15638866
[TBL] [Abstract][Full Text] [Related]
22. Simvastatin downregulates adipogenesis in 3T3-L1 preadipocytes and orbital fibroblasts from Graves' ophthalmopathy patients.
Shahida B; Johnson PS; Jain R; Brorson H; Åsman P; Lantz M; Planck T
Endocr Connect; 2019 Sep; 8(9):1230-1239. PubMed ID: 31394503
[TBL] [Abstract][Full Text] [Related]
23. Differential Gene Expression Profiling of Orbital Adipose Tissue in Thyroid Orbitopathy.
Khong JJ; Wang LY; Smyth GK; McNab AA; Hardy TG; Selva D; Llamas B; Jung CH; Sharma S; Burdon KP; Ebeling PR; Craig JE
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6438-47. PubMed ID: 26444724
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression.
Salvi M; Vannucchi G; Campi I; Rossi S; Bonara P; Sbrozzi F; Guastella C; Avignone S; Pirola G; Ratiglia R; Beck-Peccoz P
Eur J Endocrinol; 2006 Apr; 154(4):511-7. PubMed ID: 16556712
[TBL] [Abstract][Full Text] [Related]
25. [Is incidence of diplopia after Fat Removal Orbital Decompression a predictive factor of choice of surgical technique for Graves' ophthalmopathy?].
Adenis JP; Camezind P; Robert PY
Bull Acad Natl Med; 2003; 187(9):1649-58; discussion 1659-60. PubMed ID: 15369235
[TBL] [Abstract][Full Text] [Related]
26. Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion.
Kireeva ML; MO FE; Yang GP; Lau LF
Mol Cell Biol; 1996 Apr; 16(4):1326-34. PubMed ID: 8657105
[TBL] [Abstract][Full Text] [Related]
27. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy.
Konuk O; Atasever T; Unal M; Ayvaz G; Yetkin I; Cakir N; Arslan M; Hasanreisoglu B
Thyroid; 2002 Jul; 12(7):603-8. PubMed ID: 12193305
[TBL] [Abstract][Full Text] [Related]
28. Demonstration of thyrotropin receptor mRNA in orbital fat and eye muscle tissues from patients with Graves' ophthalmopathy by in situ hybridization.
Wu SL; Yang CS; Wang HJ; Liao CL; Chang TJ; Chang TC
J Endocrinol Invest; 1999 Apr; 22(4):289-95. PubMed ID: 10342363
[TBL] [Abstract][Full Text] [Related]
29. Endoscopic orbital decompression for Graves' ophthalmopathy.
Levy J; Puterman M; Lifshitz T; Marcus M; Segal A; Monos T
Isr Med Assoc J; 2004 Nov; 6(11):673-6. PubMed ID: 15562804
[TBL] [Abstract][Full Text] [Related]
30. Promoter function of the angiogenic inducer Cyr61gene in transgenic mice: tissue specificity, inducibility during wound healing, and role of the serum response element.
Latinkic BV; Mo FE; Greenspan JA; Copeland NG; Gilbert DJ; Jenkins NA; Ross SR; Lau LF
Endocrinology; 2001 Jun; 142(6):2549-57. PubMed ID: 11356704
[TBL] [Abstract][Full Text] [Related]
31. Quantitative computed tomography of Graves' ophthalmopathy. Extraocular muscle and orbital fat in development of optic neuropathy.
Feldon SE; Lee CP; Muramatsu SK; Weiner JM
Arch Ophthalmol; 1985 Feb; 103(2):213-5. PubMed ID: 3838463
[TBL] [Abstract][Full Text] [Related]
32. Chitosan inhibits inflammation and adipogenesis of orbital fibroblasts in Graves ophthalmopathy.
Xiong H; Wu M; Zou H; Jiang S; Yi H; Yi T; Wang Q; Liu D; Zhou Y; Wei C; Zhou X
Mol Vis; 2018; 24():509-517. PubMed ID: 30090014
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic criteria for Graves' ophthalmopathy.
Bartley GB; Gorman CA
Am J Ophthalmol; 1995 Jun; 119(6):792-5. PubMed ID: 7785696
[TBL] [Abstract][Full Text] [Related]
34. TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients.
Wakelkamp IM; Bakker O; Baldeschi L; Wiersinga WM; Prummel MF
Clin Endocrinol (Oxf); 2003 Mar; 58(3):280-7. PubMed ID: 12608932
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy.
Jyonouchi SC; Valyasevi RW; Harteneck DA; Dutton CM; Bahn RS
Thyroid; 2001 Oct; 11(10):929-34. PubMed ID: 11716039
[TBL] [Abstract][Full Text] [Related]
36. The role of 11beta-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy.
Tomlinson JW; Durrani OM; Bujalska IJ; Gathercole LL; Tomlins PJ; Reuser TT; Rose GE; Curnow SJ; Stewart PM; Walker EA; Rauz S
J Clin Endocrinol Metab; 2010 Jan; 95(1):398-406. PubMed ID: 19880789
[TBL] [Abstract][Full Text] [Related]
37. Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy.
Colao A; Lastoria S; Ferone D; Pivonello R; Macchia PE; Vassallo P; Bonavolonta G; Muto P; Lombardi G; Fenzi G
J Clin Endocrinol Metab; 1998 Nov; 83(11):3790-4. PubMed ID: 9814448
[TBL] [Abstract][Full Text] [Related]
38. [Detection, localization and modulation of hyaluronic acid/CD44 receptor expression in patients with endocrine orbitopathy].
Heufelder AE; Bahn RS; Boergen KP; Scriba PC
Med Klin (Munich); 1993 Apr; 88(4):181-4, 277. PubMed ID: 8492772
[TBL] [Abstract][Full Text] [Related]
39. Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy.
Hiromatsu Y; Yang D; Bednarczuk T; Miyake I; Nonaka K; Inoue Y
J Clin Endocrinol Metab; 2000 Mar; 85(3):1194-9. PubMed ID: 10720061
[TBL] [Abstract][Full Text] [Related]
40. The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy.
Prummel MF; Gerding MN; Zonneveld FW; Wiersinga WM
Clin Endocrinol (Oxf); 2001 Feb; 54(2):205-9. PubMed ID: 11207635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
